Park Avenue Securities LLC Acquires 784 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Park Avenue Securities LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 15,724 shares of the medical equipment provider's stock after buying an additional 784 shares during the quarter. Park Avenue Securities LLC's holdings in Intuitive Surgical were worth $8,207,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of ISRG. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the 3rd quarter worth $33,000. Mark Sheptoff Financial Planning LLC bought a new position in shares of Intuitive Surgical in the second quarter worth $37,000. Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical during the third quarter valued at $38,000. Finally, DT Investment Partners LLC raised its stake in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock valued at $40,000 after purchasing an additional 36 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded up $3.97 during trading hours on Thursday, hitting $584.08. 2,119,290 shares of the company's stock traded hands, compared to its average volume of 1,655,838. The stock's fifty day moving average price is $538.34 and its two-hundred day moving average price is $497.08. The firm has a market cap of $208.04 billion, a P/E ratio of 93.90, a P/E/G ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $355.17 and a twelve month high of $585.50.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research analyst reports. Oppenheimer reissued a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. Raymond James upped their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research report on Monday, October 14th. JPMorgan Chase & Co. boosted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. Finally, Evercore ISI reaffirmed a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $554.17.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,190 shares of company stock valued at $25,012,927. Corporate insiders own 0.80% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.